Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup

New England Journal of Medicine ◽

10.1056/nejme2103108 ◽

2021 ◽

Vol 384 (16) ◽

pp. 1564-1565 ◽

Author(s):

Eric J. Rubin ◽

Dan L. Longo ◽

Lindsey R. Baden

Keyword(s):

Interleukin 6 ◽

Receptor Inhibition ◽

Inflammatory Soup ◽

Interleukin 6 Receptor

Download Full-text

Faculty Opinions recommendation of Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108512.564581 ◽

2008 ◽

Author(s):

Johanne Martel-Pelletier ◽

Jean-Pierre Raynauld

Keyword(s):

Rheumatoid Arthritis ◽

Interleukin 6 ◽

Randomised Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Receptor Inhibition ◽

Interleukin 6 Receptor

Download Full-text

THU0028 Interleukin-6 receptor inhibition, as first-line b-dmard, affects b cell subpopulations distribution through epigenetic modifications in rheumatoid arthritispatients

10.1136/annrheumdis-2018-eular.4809 ◽

2018 ◽

Author(s):

S. Alivernini ◽

B. Tolusso ◽

A.L. Fedele ◽

C. Di Mario ◽

L. Petricca ◽

...

Keyword(s):

B Cell ◽

Interleukin 6 ◽

Epigenetic Modifications ◽

Receptor Inhibition ◽

Interleukin 6 Receptor ◽

Cell Subpopulations

Download Full-text

Interleukin-6 receptor inhibition with tocilizumab in various renal involvements associated with multicentric Castleman's disease: a report of three cases

Clinical Kidney Journal ◽

10.1093/ndtplus/sfn157 ◽

2008 ◽

Vol 1 (6) ◽

pp. 423-426 ◽

Author(s):

H. Komaba ◽

T. Nakazawa ◽

Y. Yamaguchi ◽

S. Kumagai ◽

M. Fukagawa

Keyword(s):

Interleukin 6 ◽

Castleman’S Disease ◽

Castleman's Disease ◽

Multicentric Castleman’S Disease ◽

Receptor Inhibition ◽

Interleukin 6 Receptor ◽

Multicentric Castleman's Disease

Download Full-text

Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: The role of acute-phase reactants

Arthritis & Rheumatism ◽

10.1002/art.27740 ◽

2010 ◽

Vol 63 (1) ◽

pp. 43-52 ◽

Author(s):

Josef S. Smolen ◽

Daniel Aletaha

Keyword(s):

Rheumatoid Arthritis ◽

Acute Phase ◽

Interleukin 6 ◽

Acute Phase Reactants ◽

Disease Remission ◽

Receptor Inhibition ◽

Interleukin 6 Receptor

Download Full-text

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Yearbook of Dermatology and Dermatologic Surgery ◽

10.1016/s0093-3619(08)79179-2 ◽

2009 ◽

Vol 2009 ◽

pp. 243-244

Author(s):

B.H. Thiers

Keyword(s):

Rheumatoid Arthritis ◽

Interleukin 6 ◽

Randomised Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Receptor Inhibition ◽

Interleukin 6 Receptor

Download Full-text

Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction

International Journal of Cardiology ◽

10.1016/j.ijcard.2018.04.136 ◽

2018 ◽

Vol 271 ◽

pp. 1-7 ◽

Author(s):

Ola Kleveland ◽

Thor Ueland ◽

Gabor Kunszt ◽

Marte Bratlie ◽

Arne Yndestad ◽

...

Keyword(s):

Myocardial Infarction ◽

Interleukin 6 ◽

St Elevation Myocardial Infarction ◽

Receptor Inhibition ◽

Interleukin 6 Receptor ◽

Download Full-text

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Yearbook of Medicine ◽

10.1016/s0084-3873(09)79339-3 ◽

2009 ◽

Vol 2009 ◽

pp. 8-12

Author(s):

S.M. Berney

Keyword(s):

Rheumatoid Arthritis ◽

Interleukin 6 ◽

Randomised Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Receptor Inhibition ◽

Interleukin 6 Receptor

Download Full-text

A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis

Atherosclerosis ◽

10.1016/j.atherosclerosis.2011.09.015 ◽

2011 ◽

Vol 219 (2) ◽

pp. 734-736 ◽

Author(s):

A.D. Protogerou ◽

E. Zampeli ◽

K. Fragiadaki ◽

K. Stamatelopoulos ◽

C. Papamichael ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Pilot Study ◽

Endothelial Dysfunction ◽

Interleukin 6 ◽

Aortic Stiffness ◽

Receptor Inhibition ◽

Interleukin 6 Receptor

Download Full-text

Assessment of Interleukin-6 Receptor Inhibition Therapy on Periodontal Condition in Patients With Rheumatoid Arthritis and Chronic Periodontitis

Journal of Periodontology ◽

10.1902/jop.2013.120696 ◽

2014 ◽

Vol 85 (1) ◽

pp. 57-67 ◽

Author(s):

Tetsuo Kobayashi ◽

Moe Okada ◽

Satoshi Ito ◽

Daisuke Kobayashi ◽

Kohei Ishida ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Interleukin 6 ◽

Chronic Periodontitis ◽

Periodontal Condition ◽

Receptor Inhibition ◽

Interleukin 6 Receptor

Download Full-text

Human myeloma cells shed the interleukin‐6 receptor: inhibition by tissue inhibitor of metalloproteinase‐3 and a hydroxamate‐based metalloproteinase inhibitor

British Journal of Haematology ◽

10.1046/j.1365-2141.1998.00754.x ◽

1998 ◽

Vol 101 (4) ◽

pp. 694-702 ◽

Author(s):

Philip G. Hargreaves ◽

Fengfei Wang ◽

Jennifer Antcliff ◽

Gillian Murphy ◽

John Lawry ◽

...

Keyword(s):

Interleukin 6 ◽

Tissue Inhibitor Of Metalloproteinase ◽

Tissue Inhibitor ◽

Myeloma Cells ◽

Metalloproteinase Inhibitor ◽

Receptor Inhibition ◽

Interleukin 6 Receptor ◽

Human Myeloma Cells

Download Full-text